Adis Journals
Browse

Cost-Effectiveness and Public Health Impact of Universal Prophylaxis with Nirsevimab Against Respiratory Syncytial Virus (RSV) Infections in all Infants in Japan

Download (553.4 kB)
media
posted on 2025-03-13, 13:34 authored by Adis journals on behalf of, Shinichi Noto, Alexia Kieffer, Samira Soudani, Takeshi Arashiro, Chiho Tadera, Sebastien Eymere, Tobiasz Lemański, Xinyu Wang

  

The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. In the meantime, a pre-typeset version of the article is attached. This is not the final publication and may be subject to some minor changes.

History

Usage metrics

    Infectious Diseases and Therapy

    Categories

    Keywords

    RSVrespiratory syncytial viruslower respiratory tract diseaseburdennirsevimabimmunizationeconomiccost-effectivenessinfantsJapan

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC